28results about "Monocomponent polypeptides artificial filament" patented technology

The present invention provides polypeptides comprising from N-terminus to C-terminus: an N-terminal capping sequence; at least two beta solenoid domains, wherein the at least two beta solenoid domains are linked by a sequence having a minimum predicted local distance difference test (pLDDT) score of 50% or more; and a C-terminal capping sequence.

Method of forming a collagenous textile filament comprising supporting a continuous thread of collagenous extrudate on a moving build platform through the liquid of a fibrillation bath; transferring t

The present invention relates to a method for air jet texturizing or air entangling a silk filament or multifilament. Further, the present invention relates to a texturized or entangled silk filament or multifilament obtained by this method. Furthermore, the present invention relates to a yarn comprising the texturized or entangled silk filament or multifilament. In addition, the present invention relates to the use of the silk filament, multifilament, or yarn in the textile industry.

A fiber comprising a lamin system protein, the fiber being characterized by a diameter of 10 μm to 180 μm. Additionally, articles comprising the fiber and methods of making the same are disclosed.

The present invention provides a modified fibroin fiber having a shrinkage history of being irreversibly shrunk after spinning, the modified fibroin fiber containing modified fibroin, wherein a fiber diameter of a raw material fiber before being irreversibly shrunk exceeds 25 μm.

The invention relates to the modified sericin obtained as a result of modification of the sericin protein, one of the silk proteins, with amines, the nanofiber composite produced from said modified sericin, and the production method of this composite. In the invention, the functionality of the sericin is increased as a result of nucleophilic substitution with amines, and composites are produced from the modified sericin with increased functionality. The nanofiber composite subject to the invention can be used in many fields, especially chemistry, biomedicine and medicine, with its high oxygen permeability, similarity to extracellular matrix (ECM) structural components, high surface / volume ratio and adjustable pore size.

Disclosed is a method of forming a collagenous textile filament. The method comprises supporting a continuous thread of collagenous extrudate upon a moving build platform surface through the liquid of a fibrillation bath; transferring the thread of collagenous extrudate to at least one drying module; and moving the thread of collagenous extrudate through the or each drying module. In the or each drying module, the thread moves unsupported through a drying cavity from a first roller to a second roller spaced apart from the first roller. The or each drying cavity is warmed by at least one heater. Also disclosed are related apparatus, products and uses of the collagenous textile filament.

Provided herein are scalable methods of processing wet-spun fiber comprising recombinant spider silk polypeptides to generate a three-dimensional crystalline lattice of beta-sheet structures in the fiber.

The present disclosure provides methods and compositions for directed to synthetic block copolymer proteins, expression constructs for their secretion, recombinant microorganisms for their production, and synthetic fibers (including advantageously, microfibers) comprising these proteins that recapitulate many properties of natural silk. The recombinant microorganisms can be used for the commercial production of silk-like fibers.

Fibers comprising a lamin-based protein, wherein the fiber is characterized by a diameter between 10 μm and 180 μm are disclosed. Further, articles comprising the fibers and methods for producing same are disclosed.

The present invention concerns an isolated recombinant nucleic acid molecule comprising at least one nucleic acid sequence encoding at least one mink hair keratin protein and further comprising a heterologous promoter controlling the expression of said at least one nucleic acid sequence, as well as an expression vector comprising said nucleic acid molecule, a host cell comprising said nucleic acid molecule or said expression vector and a method of production of mink hair keratin protein using said nucleic acid molecule.

The present invention provides a modified fibroin fiber having a shrinkage history of being irreversibly shrunk after spinning, the modified fibroin fiber containing modified fibroin, and the fiber diameter of the raw fiber before being irreversibly shrunk is greater than 25 μm.

The present invention provides fibers for rubber reinforcement which are able to be produced using a bio-derived starting material, and which are not susceptible to breaking even if complexed with a rubber material. First fibers for rubber reinforcement according to the present invention are characterized by using protein fibers that contain a hydrophobic protein. Second fibers for rubber reinforcement according to the present invention are characterized by using protein fibers that have an initial tensile elastic modulus of 2.0 GPa or more in a wet state. These fibers for rubber reinforcement are preferably provided with coating layers in the surfaces, said coating layers being formed from an aqueous adhesive composition.

Fibers comprising a lamin-based protein, wherein the fiber is characterized by a diameter between 10 μm and 180 μm are disclosed. Further, articles comprising the fibers and methods for producing same are disclosed.

The present invention concerns an isolated recombinant nucleic acid molecule comprising at least one nucleic acid sequence encoding at least one mink hair keratin protein and further comprising a heterologous promoter controlling the expression of said at least one nucleic acid sequence, as well as an expression vector comprising said nucleic acid molecule, a host cell comprising said nucleic acid molecule or said expression vector and a method of production of mink hair keratin protein using said nucleic acid molecule.

Filaments comprising a semi-crystalline polymer are disclosed herein. Also disclosed are processes for the production of filaments, cartridges comprising filaments, bioreactors comprising filaments, food products comprising filaments, cordage comprising filaments, woven materials comprising filaments, non-woven materials comprising filaments, and sutures comprising filaments.

Disclosed herein is a synthetic biology approach enabling microbial production of titin proteins, including titin oligomers and titin polymers, that yield fibers with exceptional mechanical properties derived from a unique structure-function relationship.

Disclosed is a method of forming a collagenous textile filament. The method comprises supporting a continuous thread of collagenous extrudate upon a moving build platform surface through the liquid of a fibrillation bath; transferring the thread of collagenous extrudate to at least one drying module; and moving the thread of collagenous extrudate through the or each drying module. In the or each drying module, the thread moves unsupported through a drying cavity from a first roller to a second roller spaced apart from the first roller. The or each drying cavity is warmed by at least one heater. Also disclosed are related apparatus, products and uses of the collagenous textile filament.

Embodiments of the invention relate generally to electrospun fibers and, more particularly, to the controlled release of an active pharmaceutical ingredient (API) from electrospun fiber scaffolds (EFSs).

A method of forming collagen textile filaments is disclosed. The method includes supporting a continuous filament of collagen extrudate on a surface of a moving build platform through a fibrillating bath; transferring the filaments of collagen extrudate to at least one drying module; and moving the filament of collagen extrudate through the or each drying module. In the or each drying module, the thread is moved without support from the first roller through the drying chamber to a second roller spaced apart from the first roller. The or each drying chamber is heated by at least one heater. Related devices, products and uses of collagen textile filaments are also disclosed.

The present application provides fibers made from recombinant hagfish intermediate filament proteins. Methods of expressing and purifying the proteins, and methods of creating the fibers, are likewise disclosed. The method of purifying protein yields larger quantities of hagfish protein than have been previously achieved, and the fibers have the highest mechanical properties yet recorded for recombinant hagfish protein fibers.

Embodiments of the invention relate generally to electrospun fibers and, more particularly, to the controlled release of an active pharmaceutical ingredient (API) from electrospun fiber scaffolds (EFSs).